Matt Windsor
| This email address is being protected from spambots. You need JavaScript enabled to view it.
In a town hall meeting Thursday, President Ray Watts and other senior leaders explained expense reduction measures needed to address the impact of COVID-19 on UAB and the Health System. They also answered questions on plans for fall, restarting research, antibody testing and more.
UAB is part of several trials to test whether an infusion of antibodies from people who have beaten COVID-19 can help those dealing with infection or at risk for infection. Donors are needed.
Researchers in the School of Public Health illustrate how tweets labeling the novel coronavirus as the “Chinese virus” exploded across the United States.
Crenshaw to lead UAB compliance, risk efforts
Katie Crenshaw, J.D., is the new Chief Risk and Compliance Officer for UAB, effective May 15.
Trial to rapidly identify and treat the immune overreaction that may be behind some cases of severe COVID-19 is made possible through UAB Medicine’s Urgent COVID-19 Clinical Research and Laboratory Research Fund.
Coronavirus antibody testing now is available at UAB. Here’s what that means — and what it doesn’t.
Antibody testing can reveal if a person has been exposed to the novel coronavirus in the past. More research needs to be done before we know if that means they are “protected” from COVID-19.
With little more than a smartphone and his rock collection, Scott Brande, Ph.D., has captured the attention of geology educators worldwide. A new NSF grant is allowing him to expand — and explore what happens when hands-on instruction goes online.
Educating new primary care physicians about effective treatments for opioid use disorder in partnership with Cahaba Medical Care.
Is U-BRITE 2.0 right for you?
Just in time to tackle COVID-19, the Informatics Institute launches a bigger, more capable version of its team-science data platform.
